Abstract
Breast cancer is the most common malignancy (23% of all cancers), with an estimated 1.15 million new cases worldwide in 2002, and is the leading cause of cancer mortality in women (14% of female cancer deaths).1 In the U.S., 61% of new breast cancer cases are diagnosed while localized, 31% are diagnosed in a regional stage, and 6% have already metastasized to distant sites at diagnosis (stage unknown in the remaining 2%).2 Breast cancer metastasizes most often to axillary lymph nodes, but may involve any organ.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
Fentiman IS, Millis R, Sexton S, Hayward JL. Pleural effusion in breast cancer: a review of 105 cases. Cancer. 1981;47:2087-2092.
Raju RN, Kardinal CG. Pleural effusion in breast carcinoma: analysis of 122 cases. Cancer. 1981;48:2524-2527.
Wilkes JD, Fidias P, Vaickus L, Perez RP. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Center Institute. Cancer. 1995;76:1377-1387.
Buck M, Ingle JN, Giuliani ER, Gordon JR, Therneau TM. Pericardial effusion in women with breast cancer. Cancer. 1987;60:263-269.
DiBonito L, Falconieri G, Colautti I, Bonifacio D, Dudine S. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol. 1993;37:483-488.
Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer. 1985;56:905-909.
Pokieser W, Cassik P, Fischer G, Vesely M, Ulrich W, Peters-Engl C. Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor. Breast Cancer Res Treat. 2004;83:139-142.
Kamby C, Vejborg I, Kristensen B, Olsen LO, Mouridsen HT. Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences. Cancer. 1988;62:2226-2233.
DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Malignant effusive disease of the pleura and pericardium. Chest. 1997;112(4 Suppl):291S-295S.
Geisinger KR, Stanley MW, Raab SS, Silverman JF, Abati A, eds. Modern Cytopathology. Philadelphia: Churchill Livingstone; 2004.
Bedrossian CWM. Malignant Effusions. A Multimodal Approach to Cytologic Diagnosis. New York: Igaku-Shoin; 1994.
Shidham VB, Atkinson BF. Cytopathologic Diagnosis of Serous Fluids. London: Elsevier; 2007.
Naylor B. Pleural, peritoneal and pericardial effusions. In: Bibbo M, Wilbur D, eds. Comprehensive Cytopathology. Philadelphia: Elsevier; 2008:515-578.
Shidham VB, Falzon M. Serous effusions. In: Gray W, Kocjan G, eds. Diagnostic Cytopathology. London: Churchill Livingstone; 2010:115-178.
Rappa G, Lorico A. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line. Exp Cell Res. 2010;316:1576-1586.
Danner DE, Gmelich JT. A comparative study of tumor cells from metastatic carcinoma of the breast in effusions. Acta Cytol. 1975;19:509-518.
Goldberg S, Rey G, Luce D, et al. Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Occup Environ Med. 2010;67:417-421.
Pai RK, West RB. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study. Appl Immunohistochem Mol Morphol. 2009;17:202-206.
Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005;447:688-694.
Wang Z, Spaulding B, Sienko A, et al. Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma. Int J Clin Exp Pathol. 2009;2:384-389.
Ferro P, Franceschini MC, Bacigalupo B, et al. Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors. Anticancer Res. 2010;30:2377-2382.
Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens. Diagn Cytopathol. 2009;37:475-478.
Roncella S, Ferro P, Franceschini MC, et al. Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker mammaglobin. Diagn Mol Pathol. 2010;19:92-98.
Wang LJ, Greaves WO, Sabo E, et al. GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors. Appl Immunohistochem Mol Morphol. 2009;17:505-511.
Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010;23:654-661.
Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 2002;73:403-405.
Schlüter B, Gerhards R, Strumberg D, Voigtmann R. Combined detection of HER2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer. J Cancer Res Clin Oncol. 2010;136:1389-1400.
Davidson B, Konstantinovsky S, Nielsen S, et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients- a novel model for tumor progression. Clin Cancer Res. 2004;10:7335-7346.
Konstantinovsky S, Smith Y, Zilber S, Tuft Stavnes H, Becker AM, Nesland JM, Reich R, Davidson B. Breast carcinoma cells in primary tumors and effusions have different gene array profiles. J Oncol 2010; 2010:969084.
Davidson B, Dong HP, Holth A, Berner A, Risberg B. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions. Breast J. 2008;14:476-482.
Davidson B, Konstantinovsky S, Kleinberg L, et al. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol. 2006;102:453-461.
Yuan Y, Leszczynska M, Konstantinovsky S, Trope’ CG, Reich R, Davidson B. Netrin 4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors. Diagn Cytopathol. 2011;39:562-566.
Davidson B, Tuft Stavnes H, Holth A, Chen X, Yang Y, Shih IeM, Wang TL. Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions. J Cell Mol Med. 2011;15:535-544.
Davidson B, Stavnes HT, Nesland JM, Wohlschlaeger J, Yang Y, Shih IeM, Wang TL. Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions. In press, Hum Pathol.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London Limited
About this chapter
Cite this chapter
Schmitt, F., Davidson, B. (2012). Breast Carcinoma. In: Davidson, B., Firat, P., Michael, C. (eds) Serous Effusions. Springer, London. https://doi.org/10.1007/978-0-85729-697-9_4
Download citation
DOI: https://doi.org/10.1007/978-0-85729-697-9_4
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-696-2
Online ISBN: 978-0-85729-697-9
eBook Packages: MedicineMedicine (R0)